CN103432459A - Pharmaceutical composition for treating acute upper respiratory infection - Google Patents
Pharmaceutical composition for treating acute upper respiratory infection Download PDFInfo
- Publication number
- CN103432459A CN103432459A CN2013103908837A CN201310390883A CN103432459A CN 103432459 A CN103432459 A CN 103432459A CN 2013103908837 A CN2013103908837 A CN 2013103908837A CN 201310390883 A CN201310390883 A CN 201310390883A CN 103432459 A CN103432459 A CN 103432459A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- pharmaceutical composition
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating acute upper respiratory infection. The pharmaceutical composition is a medicament which is prepared from the following raw material medicines: Semen sesami nigrum, manchurian lilac barks, albizia flower, mung beans, humifuse euphorbia herb, Semen Cuscutae, scorpio, terminalia chebula retz, lophatherum gracile, rhizoma bolbostemmae, Semen Euryales, radix tinosporae, lotus stamen, Chinese violet, hawthorn, Chinese azalea flowers, longan aril, piemarker, stalactite, pokeberry root, Sedum sarmentosum, zaocys dhumnade, szechwan Chinaberry fruit, cockscomb, concha haliotidis, cortex dictamni, fructus polygoni orientalis, radix psammosilenes, potentilla chinensis, lignum pini nodi tumorisati, vine of multiflower knotweed, ovateleaf holly barks, teasel roots, roses, lindley eupatorium, pterocephalus hookeri heck, folium eriobotryae, Chinese Starjasmine Stems, flos daturae, madder, Morinda officinalis, exocarpium benincasae, Platycodon grandiflorum, spina gleditsiae, ramulus mori, Folium Turpiniae, radix ranunculi ternate, elsholtzia, dayflowers and kamuning. The pharmaceutical composition provided by the invention is reasonable in formula and exact in curative effect, and can be used for effectively treating acute upper respiratory infection.
Description
Technical field
The present invention relates to the emergency department nursing field, specifically, relate to a kind of pharmaceutical composition for the treatment of acute upper respiratory tract infection.
Background technology
Acute upper respiratory tract infection is the general title of nasal cavity, pharynx or acute throat inflammation.The commonly encountered diseases substance is virus, and minority is antibacterial.Its morbidity is without age, sex, occupation and regional difference.The general state of an illness is lighter, and the course of disease is shorter, the prognosis bona.But because sickness rate is high, there is certain infectiousness, not only affect input of labor, sometimes also can produce severe complication, should actively prevent and treat.Primary disease all can be fallen ill the whole year, but occurred frequently with winter-spring season, can mostly be and distribute by containing the virulent spittle or contaminated hands and apparatus propagation, but can be popular when abrupt change of climate.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of acute upper respiratory tract infection.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of acute upper respiratory tract infection, it is the medicament of being made by weight by following bulk drugs: 14 parts of Semen Sesami Nigrums, 5 parts of Cortex Syingae Amurensiss, 11 parts of Flos Albiziaes, 25 parts, Semen phaseoli radiati, 11 parts of Herba Euphorbiae Humifusaes, 10 parts of Semen Cuscutae, 2 parts of Scorpios, 17 parts of FRUCTUS TERMINALIAE IMMATURUS, 10 parts of Herba Lophatheris, 10 parts of Rhizoma Bolbostematiss, 8 parts of Semen Euryaless, 5 parts of Radix Tinosporaes, 6 parts of Stamen Nelumbiniss, 2 parts of Herba Violaes, 20 parts of Fructus Crataegis, 5 parts of Flos Rhododendri Mollis, 9 parts of Arillus Longans, 10 parts of Semen Abutili, 3 parts of Stalactitums, 6 parts of Radix Phytolaccaes, 14 parts of Herba Sedis, 5 parts of Zaocyss, 5 parts of Fructus Toosendans, 8 parts of Flos Celosiae Cristataes, 2 parts of Concha Haliotidis, 15 parts of Cortex Dictamni, 7 parts of Fructus Polygoni Orientaliss, 4 parts of Radix Psammosileness, 16 parts of Herba Potentillae Chinensis, 3 parts of Pine Nodular Branchs, 12 parts of Caulis Polygoni Multiflori, 2 parts of Cortex Ilicis Rotundaes, 15 parts of Radix Dipsacis, 15 parts of Flos Rosae Rugosaes, 7 parts of Herba Eupatorii Lindleyanis, 2 parts of Herba pterocephali, 17 parts of Folium Eriobotryaes, 4 parts of Caulis Trachelospermis, 7 parts of Flos Daturaes, 12 parts, Radix Rubiae, 15 parts of Radix Morindae Officinaliss, 17 parts of Exocarpium Benincasaes, 15 parts of Radix Platycodoniss, 5 parts of Spina Gleditsiaes, 5 parts of Ramulus Moris, 5 parts of leaf of Turpinia pomifera (Roxb) D O., 5 parts of Radix Ranunculi Ternatis, 5 parts of Herba Moslaes, 4 parts of 8 parts of Herba Commelinaes and Folium Et Cacumen Murrayae.
Pharmaceutical composition of the present invention can be made various dosage forms with pharmaceutically acceptable carrier, such as tablet, capsule, soft capsule, pill, granule, oral liquid or decoction etc.Can adopt preparation technique means well known in the art to complete the preparation of pharmaceutical composition of the present invention.
Described pharmaceutically acceptable carrier is well known, is the conventional excipients for the preparation of above-mentioned preparation or adjuvant.Excipient or adjuvant commonly used comprises (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant etc., for example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate etc.
The reasonable recipe of pharmaceutical composition of the present invention, curative effect is clear and definite, can effectively treat acute upper respiratory tract infection.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 drug composition oral liquid of the present invention
Take Semen Sesami Nigrum 14 grams, Cortex Syingae Amurensis 5 grams, Flos Albiziae 11 grams, Semen phaseoli radiati 25 grams, Herba Euphorbiae Humifusae 11 grams, Semen Cuscutae 10 grams, Scorpio 2 grams, FRUCTUS TERMINALIAE IMMATURUS 17 grams, Herba Lophatheri 10 grams, Rhizoma Bolbostematis 10 grams, Semen Euryales 8 grams, Radix Tinosporae 5 grams, Stamen Nelumbinis 6 grams, Herba Violae 2 grams, Fructus Crataegi 20 grams, Flos Rhododendri Mollis 5 grams, Arillus Longan 9 grams, Semen Abutili 10 grams, Stalactitum 3 grams, Radix Phytolaccae 6 grams, Herba Sedi 14 grams, Zaocys 5 grams, Fructus Toosendan 5 grams, Flos Celosiae Cristatae 8 grams, Concha Haliotidis 2 grams, Cortex Dictamni 15 grams, Fructus Polygoni Orientalis 7 grams, Radix Psammosilenes 4 grams, Herba Potentillae Chinensis 16 grams, Pine Nodular Branch 3 grams, Caulis Polygoni Multiflori 12 grams, Cortex Ilicis Rotundae 2 grams, Radix Dipsaci 15 grams, Flos Rosae Rugosae 15 grams, Herba Eupatorii Lindleyani 7 grams, Herba pterocephali 2 grams, Folium Eriobotryae 17 grams, Caulis Trachelospermi 4 grams, Flos Daturae 7 grams, Radix Rubiae 12 grams, Radix Morindae Officinalis 15 grams, Exocarpium Benincasae 17 grams, Radix Platycodonis 15 grams, Spina Gleditsiae 5 grams, Ramulus Mori 5 grams, leaf of Turpinia pomifera (Roxb) D O. 5 grams, Radix Ranunculi Ternati 5 grams, Herba Moslae 5 grams, Herba Commelinae 8 grams and Folium Et Cacumen Murrayae 4 grams, add 9000 ml waters, 90 ℃ of heating 4 hours, filters, and filtrate is concentrated into 5000ml, high speed centrifugation, and filtering with microporous membrane, in embedding to 500 bottle, sterilizing and get final product.
Experimental example
Select emergency treatment acute upper respiratory tract infection patient 60 examples, male 30 examples wherein, female's 30 examples, minimal ages 18 years old, maximum 56 years old age.Inclusive criteria: 1. meet relevant " the high heat of the acute upper respiratory tract infection " diagnostic criteria (Wu Shaozhen in " diagnosis of common disease and curative effect determinate standard ", Wu Min. the diagnosis of common disease and curative effect determinate standard [M]. Beijing: China Traditional Chinese Medicine Publishing House, 1999:140-142.): onset is anxious, the inducement such as suffer from cold, overworked or with the Patients With Respiratory Tract Infection contact history; Clinical symptoms can show as cough, expectorant is the amount doesn't matter, pharyngalgia, general pain, nasal obstruction, watery nasal discharge, hoarseness; Axillaty temperature is more than 38.5 ℃; The two lung auscultation respiratory murmurs of having a medical check-up are normal or increase thick or audible and dry, moist rales.Chest X-ray shows normal or enhanced lung markings.2. fall ill in 72h.3. the age is more than 14 years old or below 70 years old.4. without the medication contraindication.5. be not associated with cardiovascular and cerebrovascular disease and serious hepatorenal disease.6. patient's informed consent.
Therapeutic Method:
Use the oral liquid of embodiment 1 preparation to be treated, every day 2 times, each 1 bottle.Be a course for the treatment of for three days on end.
The clinical recovery criterion:
Meet " diagnosis of common disease and curative effect determinate standard " (Wu Shaozhen, Wu Min. the diagnosis of common disease and curative effect determinate standard [M]. Beijing: China Traditional Chinese Medicine Publishing House, 1999:140-142.), that is: 1. produce effects: after medication, in 24h, the cardinal symptoms such as General Symptoms and local pyrexia, cough, pharyngalgia disappear or basic the disappearance; 2. effective: in medication 24-48h, the cardinal symptoms such as General Symptoms and local pyrexia, cough, pharyngalgia disappear or basic the disappearance; 3. invalid: do not meet above standard person all be considered as invalid.
Result:
Through treatment, after all 60 patient's medications, in 24h, the cardinal symptoms such as General Symptoms and local pyrexia, cough, pharyngalgia disappear or basic the disappearance, therefore all meet the standard of produce effects.
Claims (2)
1. a pharmaceutical composition for the treatment of acute upper respiratory tract infection, is characterized in that, it is the medicament of being made by weight by following bulk drugs: 14 parts of Semen Sesami Nigrums, 5 parts of Cortex Syingae Amurensiss, 11 parts of Flos Albiziaes, 25 parts, Semen phaseoli radiati, 11 parts of Herba Euphorbiae Humifusaes, 10 parts of Semen Cuscutae, 2 parts of Scorpios, 17 parts of FRUCTUS TERMINALIAE IMMATURUS, 10 parts of Herba Lophatheris, 10 parts of Rhizoma Bolbostematiss, 8 parts of Semen Euryaless, 5 parts of Radix Tinosporaes, 6 parts of Stamen Nelumbiniss, 2 parts of Herba Violaes, 20 parts of Fructus Crataegis, 5 parts of Flos Rhododendri Mollis, 9 parts of Arillus Longans, 10 parts of Semen Abutili, 3 parts of Stalactitums, 6 parts of Radix Phytolaccaes, 14 parts of Herba Sedis, 5 parts of Zaocyss, 5 parts of Fructus Toosendans, 8 parts of Flos Celosiae Cristataes, 2 parts of Concha Haliotidis, 15 parts of Cortex Dictamni, 7 parts of Fructus Polygoni Orientaliss, 4 parts of Radix Psammosileness, 16 parts of Herba Potentillae Chinensis, 3 parts of Pine Nodular Branchs, 12 parts of Caulis Polygoni Multiflori, 2 parts of Cortex Ilicis Rotundaes, 15 parts of Radix Dipsacis, 15 parts of Flos Rosae Rugosaes, 7 parts of Herba Eupatorii Lindleyanis, 2 parts of Herba pterocephali, 17 parts of Folium Eriobotryaes, 4 parts of Caulis Trachelospermis, 7 parts of Flos Daturaes, 12 parts, Radix Rubiae, 15 parts of Radix Morindae Officinaliss, 17 parts of Exocarpium Benincasaes, 15 parts of Radix Platycodoniss, 5 parts of Spina Gleditsiaes, 5 parts of Ramulus Moris, 5 parts of leaf of Turpinia pomifera (Roxb) D O., 5 parts of Radix Ranunculi Ternatis, 5 parts of Herba Moslaes, 4 parts of 8 parts of Herba Commelinaes and Folium Et Cacumen Murrayae.
2. the pharmaceutical composition for the treatment of acute upper respiratory tract infection according to claim 1, is characterized in that, described medicament can be tablet, capsule, soft capsule, pill, granule, oral liquid or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103908837A CN103432459A (en) | 2013-09-02 | 2013-09-02 | Pharmaceutical composition for treating acute upper respiratory infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103908837A CN103432459A (en) | 2013-09-02 | 2013-09-02 | Pharmaceutical composition for treating acute upper respiratory infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103432459A true CN103432459A (en) | 2013-12-11 |
Family
ID=49686243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103908837A Pending CN103432459A (en) | 2013-09-02 | 2013-09-02 | Pharmaceutical composition for treating acute upper respiratory infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103432459A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497314A (en) * | 2016-01-04 | 2016-04-20 | 四川双鑫生物科技有限公司 | Traditional Chinese medicine composition for treating upper respiratory infection and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110910A (en) * | 2013-01-25 | 2013-05-22 | 王庆霞 | Agent for treating acute upper respiratory infection |
| CN103142982A (en) * | 2013-03-22 | 2013-06-12 | 王健 | Medicine for treating acute upper respiratory infection |
-
2013
- 2013-09-02 CN CN2013103908837A patent/CN103432459A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110910A (en) * | 2013-01-25 | 2013-05-22 | 王庆霞 | Agent for treating acute upper respiratory infection |
| CN103142982A (en) * | 2013-03-22 | 2013-06-12 | 王健 | Medicine for treating acute upper respiratory infection |
Non-Patent Citations (2)
| Title |
|---|
| 梁伟波等: "辨证为主治疗急性上呼吸道感染发热临床观察", 《新中医》, vol. 43, no. 11, 30 November 2011 (2011-11-30), pages 16 - 17 * |
| 钟邱等: "上呼吸道感染疾病中药处方用药分析", 《中医药临床杂志》, vol. 25, no. 2, 28 February 2013 (2013-02-28), pages 171 - 172 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497314A (en) * | 2016-01-04 | 2016-04-20 | 四川双鑫生物科技有限公司 | Traditional Chinese medicine composition for treating upper respiratory infection and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102114197A (en) | Traditional Chinese medicine oral decoction for treating influenza | |
| CN101502614B (en) | Medicine tea for stopping snore | |
| CN103977314A (en) | Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition | |
| CN101797295B (en) | Medicinal composition for treating infantile cough and preparation method thereof | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN105031453A (en) | Oral liquid for treating chronic bronchitis | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN103432459A (en) | Pharmaceutical composition for treating acute upper respiratory infection | |
| CN103432506B (en) | Pharmaceutical composition for treating upper respiratory infection | |
| CN103920016A (en) | Chinese medicinal tea for treating chronic sphagitis | |
| CN103432507A (en) | Medicinal composition for treating hand-foot-mouth disease | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN104606350A (en) | Medicament for treating throat-blocking abscess | |
| CN101703615B (en) | Chinese medicinal composition for treating insomnia | |
| CN102319348B (en) | Medicament for treating chronic pharyngitis | |
| CN101095824A (en) | Pharynx-cleaning detoxicating capsule | |
| CN103784753A (en) | Chinese herbal medicine formula for treating nasopharyngitis and preparation method thereof | |
| CN105288202A (en) | Pharmaceutical composition for curing infantile cough | |
| CN104800543A (en) | Traditional Chinese medicine composition for treating influenza as well as preparation method and use thereof | |
| CN104623115A (en) | Traditional Chinese medicine preparation for treating acute lymphangitis | |
| CN104606401A (en) | Medicament for treating umbilical abscess | |
| CN104688946A (en) | Medicine for treating early suppurative osteomyelitis | |
| CN102198185A (en) | Medicament for rapidly treating chronic pharyngolaryngitis | |
| CN101979080A (en) | Phlegm reducing medicament | |
| CN110934928A (en) | Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131211 |